期刊文献+

Effects of levodopa on dopaminergic neurons and induced dyskinesia A radio-imaging study 被引量:1

Effects of levodopa on dopaminergic neurons and induced dyskinesia A radio-imaging study
下载PDF
导出
摘要 BACKGROUND: Radio-imaging has been used in neurological diagnosis, in particular for extrapyramidal disease. Moreover, it has been extensively utilized for early diagnosis of Parkinson's disease (PD) patients and in animal studies. However, it has rarely been utilized to assess drug-induced side effects in PD. OBJECTIVE: To investigate changes in dopamine transporter expression in a rat model of PD through the use of radio-imaging taking ^99mTc-TRODAT-1 as an imaging agent, and to explore the effect of levodopa (L-dopa) on dopaminergic neurons and the possible mechanisms of dyskinesia induction. DESIGN, TIME AND SETTING: A randomized, controlled, animal study was performed at the Laboratory of Department of Nuclear Medicine, Soochow University from April 2006 to June 2007. MATERIALS: 6-hydroxydopamine was purchased from Sigma, USA and L-dopa was purchased from Shanghai Fuda Pharmaceutical, China. ^99mTcO4-fresh elutriant was provided by the Department of Nuclear Medicine, First Hospital Affiliated to Soochow University. TRODAT-1 image kit was provided by Jiangsu Atomic Energy Research Establishment, China. The SN-695B radioimmunoassay gamma counter was purchased from Shanghai Hesuo Rihuan Photoelectric Instrument, China. The AZ-CA256eZ-Scope portable y camera was purchased from Anzai Medical, Japan. METHODS: A total of 34 healthy, male, Sprague Dawley rats were selected. Thirty were used to establish a PD model by injecting 6-hydroxydopamine into the right medial forebrain bundle, and four were injected with normal saline and served as the sham-surgery group. At the end of 4 weeks, 21 successful PD models were selected and randomly assigned to the L-dopa (n = 15, 20 mg/kg per day), model (n = 6, normal saline), and sham-surgery (n = 4, no treatment) groups. After 1 month of treatment, involuntary movement was evaluated twice weekly in each rat. A total of 0.2 mL ^99mTc-TRODAT-1 was injected into the tail vein 2 days following drug termination, and images of dopamine transporters were acquired 2 hours later. The rats were sacrificed and the ratios of specific radioactivity uptake were calculated. MAIN OUTCOME MEASURES: Manifestations of abnormal involuntary movement (AIM) were observed and total AIM scores were calculated. Images of dopamine transporters were acquired using an eZ-Scope portable y camera, and radioactive y quantification of ^99mTC-TRODAT-1 in the rat brains was assayed. The ratios of the left and right corpora striata were determined. The number and function of dopamine transporters was evaluated according to specific radioactivity uptake ratio (R) from the left and right corpora striata. RESULTS: Of 15 PD rats, nine exhibited AIM following L-dopa treatment: five scored 〉 20, i.e., severe grade, four scored 8-16, mild grade, and the remaining exhibited normal behavior. There were no differences in specific radioactivity uptake of dopamine transporter between the left and right corpora striata in the sham-surgery rats, and the images were clear and symmetrically distributed. Specific radioactivity uptake of the normal side (left) was significantly greater than the lesioned side (right) in the model group rats (P 〈 0.01), and the R value was significantly increased compared with the sham-surgery group (P 〈 0.01). The radio-ligand accumulation in the right corpus striatum was sparse. In the L-dopa group, specific radioactivity uptake was significantly decreased in the lesioned (right) side of the AiM rats, and the Rvalue was increased compared with the model group (P 〈 0.05). The amount of radio-ligand in the right corpus striatum was diminished. The Rvalue was significantly reduced in the non-AIM rats compared with the AIM rats (P 〈 0.05), and specific radioactivity uptake was significantly increased in the lesioned (right) side compared with the normal side (P 〈 0.05). Moreover, radio-ligand accumulation was observed in the right corpus striatum, and differences in radio-ligand accumulation between the two sides were reduced. CONCLUSION: Following L-dopa treatment, the number and function of dopamine transporter in some PD rats were reduced. L-dopa was shown to be toxic to dopaminergic neurons and induced dyskinesia. BACKGROUND: Radio-imaging has been used in neurological diagnosis, in particular for extrapyramidal disease. Moreover, it has been extensively utilized for early diagnosis of Parkinson's disease (PD) patients and in animal studies. However, it has rarely been utilized to assess drug-induced side effects in PD. OBJECTIVE: To investigate changes in dopamine transporter expression in a rat model of PD through the use of radio-imaging taking ^99mTc-TRODAT-1 as an imaging agent, and to explore the effect of levodopa (L-dopa) on dopaminergic neurons and the possible mechanisms of dyskinesia induction. DESIGN, TIME AND SETTING: A randomized, controlled, animal study was performed at the Laboratory of Department of Nuclear Medicine, Soochow University from April 2006 to June 2007. MATERIALS: 6-hydroxydopamine was purchased from Sigma, USA and L-dopa was purchased from Shanghai Fuda Pharmaceutical, China. ^99mTcO4-fresh elutriant was provided by the Department of Nuclear Medicine, First Hospital Affiliated to Soochow University. TRODAT-1 image kit was provided by Jiangsu Atomic Energy Research Establishment, China. The SN-695B radioimmunoassay gamma counter was purchased from Shanghai Hesuo Rihuan Photoelectric Instrument, China. The AZ-CA256eZ-Scope portable y camera was purchased from Anzai Medical, Japan. METHODS: A total of 34 healthy, male, Sprague Dawley rats were selected. Thirty were used to establish a PD model by injecting 6-hydroxydopamine into the right medial forebrain bundle, and four were injected with normal saline and served as the sham-surgery group. At the end of 4 weeks, 21 successful PD models were selected and randomly assigned to the L-dopa (n = 15, 20 mg/kg per day), model (n = 6, normal saline), and sham-surgery (n = 4, no treatment) groups. After 1 month of treatment, involuntary movement was evaluated twice weekly in each rat. A total of 0.2 mL ^99mTc-TRODAT-1 was injected into the tail vein 2 days following drug termination, and images of dopamine transporters were acquired 2 hours later. The rats were sacrificed and the ratios of specific radioactivity uptake were calculated. MAIN OUTCOME MEASURES: Manifestations of abnormal involuntary movement (AIM) were observed and total AIM scores were calculated. Images of dopamine transporters were acquired using an eZ-Scope portable y camera, and radioactive y quantification of ^99mTC-TRODAT-1 in the rat brains was assayed. The ratios of the left and right corpora striata were determined. The number and function of dopamine transporters was evaluated according to specific radioactivity uptake ratio (R) from the left and right corpora striata. RESULTS: Of 15 PD rats, nine exhibited AIM following L-dopa treatment: five scored 〉 20, i.e., severe grade, four scored 8-16, mild grade, and the remaining exhibited normal behavior. There were no differences in specific radioactivity uptake of dopamine transporter between the left and right corpora striata in the sham-surgery rats, and the images were clear and symmetrically distributed. Specific radioactivity uptake of the normal side (left) was significantly greater than the lesioned side (right) in the model group rats (P 〈 0.01), and the R value was significantly increased compared with the sham-surgery group (P 〈 0.01). The radio-ligand accumulation in the right corpus striatum was sparse. In the L-dopa group, specific radioactivity uptake was significantly decreased in the lesioned (right) side of the AiM rats, and the Rvalue was increased compared with the model group (P 〈 0.05). The amount of radio-ligand in the right corpus striatum was diminished. The Rvalue was significantly reduced in the non-AIM rats compared with the AIM rats (P 〈 0.05), and specific radioactivity uptake was significantly increased in the lesioned (right) side compared with the normal side (P 〈 0.05). Moreover, radio-ligand accumulation was observed in the right corpus striatum, and differences in radio-ligand accumulation between the two sides were reduced. CONCLUSION: Following L-dopa treatment, the number and function of dopamine transporter in some PD rats were reduced. L-dopa was shown to be toxic to dopaminergic neurons and induced dyskinesia.
出处 《Neural Regeneration Research》 SCIE CAS CSCD 2010年第2期92-97,共6页 中国神经再生研究(英文版)
基金 the Scientific Research Foundation Program of Ministry of Health,No.wkj.2005-2-030
关键词 Parkinson's disease LEVODOPA dopamine transporter ^99MTC-TRODAT-1 NEUROIMAGING neural regeneration Parkinson's disease levodopa dopamine transporter ^99mTc-TRODAT-1 neuroimaging neural regeneration
  • 相关文献

参考文献2

二级参考文献12

  • 1Lee CS,Saver H,Bjorklund A. Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by intrastriatal 6-hydroxydopamine in the rat [J]. Neuroscience, 1996,72 (3) : 641-653.
  • 2Sengstick GJ,Olanow CW,Dunn AJ,et al. Progressive changes in striatal dopaminergic markers,nigral volume and rotational behavior following iron infusion into the rat substantia nigra[J]. Experimental Neurology, 1994,130 (1) : 82- 94.
  • 3He Y,Thong PS,Lee T,et al. Increased iron in the substantia nigra of 6-OHDA induced Parkinsonian rats,a nuclear microscopy study[J]. Brain Research,1996,735(1):149-153.
  • 4Thomas J, Wang J, Takubo H, et al. A 6-hydroxydopamine-induced selective Parkinsonian rat model:further biochemical and behavioral characterization[J]. Experimental Neurology, 1994, 126(2):159-167.
  • 5Bustany P, Trenque T, Crambes O, et al. Restoration of brain protein synthesis in mature and aged rats by a DA agonist, Piribedil.Fundam Clin Pharmacol, 1995, 9(5) : 458.
  • 6Yang Min ,Pei Zhuguo, Hu Minyang,et al. Synthesis and Labelling of Epidepride. Nuclear Science and Techniques,2001,12(2) :111.
  • 7Guttman M, Stewart D, Hussey D, et al. Influence of L-dopa and pramipxole on Striatlal dopamine transporter in early PD. Neurology,2001,56( 11 ) : 1559.
  • 8Linazasoro G, Obeso JA, Gomez JC,et al. Modification of Dopamine D2 Receptor Activity by Pergolide in Parkinson's Disease: An in vivo Study by PET. Clin Neuropharmacol, 1999, 22(5) : 277.
  • 9Deleu D, Northway MG, Hanssens Y, et al. Clinical pharmacokinetic and phannacodynamic properties of drugs used in the treatment of Parkinson's disease. Clin Pharmacokinet,2002,41 (4) :261.
  • 10陈玲,刘焯霖,黎锦如,吴克宁,潘勇辉,李春亿,李伟明,胡平.吡贝地尔对帕金森病猴模型脑多巴胺转运体影响的实验研究[J].中国神经精神疾病杂志,2002,28(1):60-60. 被引量:1

共引文献9

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部